Blackstone to acquire a 60% stake in CMIC.

The Blackstone Group, an American multinational private equity, alternative asset management, and financial services firm that specializes in credit and hedge fund investment strategies, agreed to acquire a 60% stake in CMIC, a contract research organization that provides comprehensive end-to-end services across clinical trial phases and therapeutic areas. Financial terms were not disclosed. This investment underscores Blackstone’s commitment to investing in Japan’s healthcare services sector, where it has deep expertise and network.